Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

MS Comorbidities Impact Clinical Outcomes

Mult Scler J; ePub 2016 May 26; Conway, et al

Publish date:: June 7, 2016

Hypertension, diabetes, and obstructive lung disease impacted clinical outcomes, including walking speed, self-reported disability, and depression, in patients with multiple sclerosis (MS), a recent study found. Researchers evaluated the Knowledge Program, a database linked to an electronic medical record allowing capture of patient and clinician reported outcomes. They identified all relapsing-remitting MS patients seen between January 1, 2010, and May 29, 2012, and acquired their magnetic resonance imaging (MRI) results and comorbidities. They found:

• Hypertension had the greatest effect on clinical outcomes.

• Hyperlipidemia did not impact clinical outcomes.

• The presence of multiple comorbidities had a cumulative effect on clinical outcomes.

• MRI outcomes were unaffected by comorbidities.

Citation: Conway DS, Thompson NR, Cohen JA. Influence of hypertension, diabetes, hyperlipidemia, and obstructive lung disease on multiple sclerosis disease course. [Published online ahead of print May 26, 2016]. Mult Scler J. doi:10.1177/1352458516650512.

This Week's Must Reads

COVID-19 vaccine found effective but doctors watching for reactions, adverse events,

Study links sleep meds and dementia risk in older adults,

Childhood Hodgkin survivors have neurocognitive impairment,

Obesity, hypoxia predict severity in children with COVID-19,

Long-term safety and efficacy of teriflunomide for relapsing MS,

Must Reads in Multiple Sclerosis

Long-term safety and efficacy of teriflunomide for relapsing MS,

Newer DMTs are more effective than injectable DMTs in pediatric MS,

Neutrophil granulocyte markers may distinguish between demyelinating diseases,

Bacteria may be associated with risk of MS relapse,

Women with MS may have increased subclinical disease activity during pregnancy,